Impact of antiretroviral resistance and virological failure on HIV-1 informational entropy

被引:3
|
作者
de Carvalho Lima, Elidamar Nunes [1 ,2 ]
Castilho Piqueira, Jose Roberto [2 ]
Camargo, Michelle [1 ]
Galinskas, Juliana [1 ]
Sucupira, Maria Cecilia [1 ]
Diaz, Ricardo Sobhie [1 ]
机构
[1] Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Div Infect Dis, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Sch Engn, Telecommun & Control Engn Dept, Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; T-LYMPHOCYTE EPITOPES; VIRAL FITNESS; REVERSE-TRANSCRIPTASE; SELECTION PRESSURE; PROTEASE; MUTATIONS; EVOLUTION; SYSTEMS;
D O I
10.1093/jac/dkx508
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The present study investigated the relationship between genomic variability and resistance of HIV-1 sequences in protease (PR) and reverse transcriptase (RT) regions of the pol gene. In addition, we analysed the resistance among 651 individuals presenting antiretroviral virological failure, from 2009 to 2011, in the state of Sao Paulo, Brazil. Methods: The genomic variability was quantified by using informational entropy methods and the relationship between resistance and replicative fitness, as inferred by the residual viral load and CD4+ T cell count. Results: The number of antiretroviral schemes is related to the number of resistance mutations in the HIV-1 PR (alpha = 0.2511, P = 0.0003, R-2 = 0.8672) and the RT (alpha = 0.7892, P = 0.0001, R-2 = 0.9141). Increased informational entropy rate is related to lower levels of HIV-1 viral loads (alpha = -0.0121, P = 0.0471, R-2 = 0.7923), lower levels of CD4+ T cell counts (alpha = -0.0120, P = 0.0335, R-2 = 0.8221) and a higher number of antiretroviral resistance-related mutations. Conclusions: Less organized HIV genomes as inferred by higher levels of informational entropy relate to less competent host immune systems, lower levels of HIV replication and HIV genetic evolution as a consequence of antiretroviral resistance.
引用
收藏
页码:1054 / 1059
页数:6
相关论文
共 50 条
  • [41] Immunological and Virological Responses to Highly Active Antiretroviral Therapy in HIV-1 Infected Children
    Ravinder Singh
    Aparna Mukherjee
    Mohit Singla
    Bimal Kumar Das
    Sushil Kumar Kabra
    Rakesh Lodha
    The Indian Journal of Pediatrics, 2017, 84 : 893 - 896
  • [42] Immunological and Virological Responses to Highly Active Antiretroviral Therapy in HIV-1 Infected Children
    Singh, Ravinder
    Mukherjee, Aparna
    Singla, Mohit
    Das, Bimal Kumar
    Kabra, Sushil Kumar
    Lodha, Rakesh
    INDIAN JOURNAL OF PEDIATRICS, 2017, 84 (12): : 893 - 896
  • [43] Virological Failure and HIV-1 Drug Resistance Mutations among Naive and Antiretroviral Pre-Treated Patients Entering the ESTHER Program of Calmette Hospital in Cambodia
    Barennes, Hubert
    Guillet, Stephanie
    Limsreng, Setha
    Him, Sovanvatey
    Nouhin, Janin
    Hak, Chanroeurn
    Srun, Chanvatey
    Viretto, Gerald
    Ouk, Vara
    Delfraissy, Jean Francois
    Segeral, Olivier
    PLOS ONE, 2014, 9 (08):
  • [44] Association between nucleoside reverse transcriptase inhibitors resistance mutations and level of residual HIV-1 viraemia under antiretroviral treatment in patients experiencing virological failure
    Roquebert, B
    Dalban, C
    Wirden, M
    Tubiana, R
    Valantin, MA
    Bonmarchand, M
    Simon, A
    Katlama, C
    Costagliola, D
    Calvez, V
    Marcelin, AG
    ANTIVIRAL THERAPY, 2005, 10 (04) : S24 - S24
  • [45] Association between nucleoside reverse transcriptase inhibitors resistance mutations and level of residual HIV-1 viraemia under antiretroviral treatment in patients experiencing virological failure
    Roquebert, B
    Dalban, C
    Wirden, M
    Tubiana, R
    Valantin, MA
    Bonmarchand, M
    Simon, A
    Katlama, C
    Costagliola, D
    Calvez, V
    Marcelin, AG
    ANTIVIRAL THERAPY, 2005, 10 : S24 - S24
  • [46] Lamivudine-based maintenance antiretroviral therapies in patients living with HIV-1 with suppressed HIV RNA: derivation of a predictive score for virological failure
    Borghetti, A.
    Moschese, D.
    Cingolani, A.
    Baldin, G.
    Speziale, D.
    Ciccullo, A.
    Lombardi, F.
    Emiliozzi, A.
    Belmonti, S.
    Antinori, A.
    Cauda, R.
    Di Giambenedetto, S.
    HIV MEDICINE, 2019, 20 (09) : 624 - 627
  • [47] Ultradeep HIV-1 sequencing analysis from subjects experiencing virological failure in the ARIES study: assessment of the impact of low-abundance HIV-1 variants on resistance mutation selection pathways
    Ross, L. L.
    Squires, K.
    Young, B.
    DeJesus, E.
    Bellos, N.
    Murphy, D.
    Zhao, H.
    Blackmon, E.
    Wine, B.
    Horton, J.
    Shaefer, M.
    ANTIVIRAL THERAPY, 2011, 16 : A77 - A77
  • [48] Epidemiology of transmitted drug resistance mutations in an HIV-1 subtype C high-prevalence setting and impact on 1-year virological failure
    Moro, Ana Lucia D.
    Rigatto, Maria Helena
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 20 : 33 - 35
  • [49] HIV-1 Antiretroviral Resistance in Cuba, 2009-2014
    Aleman-Campos, Yoan
    Kouri-Cordella, Vivian
    Perez-Santos, Lissette
    Fonseca-Gomez, Carlos
    Perez-Avila, Jorge
    Ortega-Gonzalez, Lilia M.
    Banos-Morales, Yoanna
    Alvarez-Lopez, Alina
    Correa-Sierra, Consuelo B.
    Martinez-Montesinos, Yenisleidys
    Soto-Brito, Yudira
    Limia-Leon, Celia M.
    Campos-Diaz, Jorge R.
    Caturla-Fernandez, Yaniris
    Alvarez-Gainza, Delmis
    Pintos-Saavedra, Yanet
    Ane-Kouri, Ana L.
    Joanes-Fiol, Jose
    MEDICC REVIEW, 2018, 20 (03) : 15 - 21
  • [50] HIV-1 Antiretroviral Resistance: Scientific Principles and Clinical Applications
    Tang, Michele W.
    Shafer, Robert W.
    DRUGS, 2012, 72 (09) : E1 - E25